ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SCLP Scancell Holdings Plc

10.10
0.00 (0.00%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Holdings Plc LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 10.10 9.70 10.50 10.10 10.10 10.10 177,070 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 5.27M -11.94M -0.0129 -7.83 93.71M
Scancell Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 10.10p. Over the last year, Scancell shares have traded in a share price range of 7.65p to 18.125p.

Scancell currently has 927,819,977 shares in issue. The market capitalisation of Scancell is £93.71 million. Scancell has a price to earnings ratio (PE ratio) of -7.83.

Scancell Share Discussion Threads

Showing 60826 to 60844 of 67200 messages
Chat Pages: Latest  2436  2435  2434  2433  2432  2431  2430  2429  2428  2427  2426  2425  Older
DateSubjectAuthorDiscuss
29/4/2023
18:23
Tf and Huh !! you posted

""""I am FOR good vaccines ""but"" as AB notes in passing, the AstraZeneca vaccine has quietly disappeared from the NHS and the current MRNA vaccines are no longer recommended for 6 month old babies - in fact, promoted now only for over 75's and those of extreme vulnerability."""

you used "but" implying that vaccines had issues

Astra z dropped off the list because it didn't control variants

I have no interest in viral vaccines unless scancell pull off a deal

we did well out of the Gov grant ... we got a new cancer vaccine and patent out of it

if the Gov is not prepared to fund alternatives .......... not a lot we can do and if under 75's have dropped of the yearly radar then that makes the market pretty small but is that medical or blown budgets ?

inanaco
29/4/2023
15:09
Inan 57108 - uuh?

No - what do you think of these moves at the WHA/WHO ?

torquayfan
29/4/2023
13:34
Quite amazing really -
As the BUY,BUY,BUY this overhyped 'Dead money', much diluted, "NO RISK here" FAILED effort is well into it's second DECADE of wasted money/time.
And YET, the deluded trHYPE gang/ remaining trHYPE swallowers STILL persist in CLAIMING a non existing 'superior' insight.
Meanwhile,the WISER, more ASTUTE observe the amazing self delution of the non appearance of the "WE are MINTED" greed mentality...Whilst insisting for over a DECADE that 'the markets are WRONG ...don't know what they are doing'.
REALITY = the "WE are MINTED" greed mentality...Slump from £1, £6, £8+ a share CLAIMS to 40p as being "MINTED"
Over a wasted DECADE in the making = What a CLIMBDOWN

the real lozan
29/4/2023
11:00
Lozan ...

i am not promoting scancell indeed i am buying up shares ... with over 1.3m now i am more than happy to sit here with a £200,000 punt on Lindy ....

sadly BetFred have not offered odds on you proving IQ156 but i would be happy to bet on failure if offered

I have my Annual Bet with Ivy .... which like last year was running neck and neck at this stage

all to play for ... but you won't find us on the green at the crucible

inanaco
29/4/2023
10:55
Scancell
@scancellpharma
Today, 29th April 2023, is World Immunology Day. To commemorate this day, we are sharing our latest article that highlights our ground-breaking approach to developing innovative #cancer #vaccines.
Follow the link to read the paper:


These results suggest siPTM-peptides are presented under conditions of cellular stress and inflammation and drive cytotoxic CD4 T cell responses that aid in the removal of stressed cells. The presentation of such siPTM-peptides is not restricted to HLA-SE in both humans and animal models.

marcusl2
29/4/2023
10:51
i think your getting confused with what is needed TF ie recommended and blaming that restriction on vaccine safety issues .... when that is NOT the case

i suggest you study before your next comment

I refer you to Gov websites




and

you can still get your First and second dose on the NHS

Getting a 1st and 2nd dose of the COVID-19 vaccine
Who can get a 1st and 2nd dose
Everyone aged 5 (on or before 31 August 2022) and over can get a 1st and 2nd dose of the COVID-19 vaccine.

Children who turned 5 on or after 1 September 2022 can only get a 1st and 2nd dose of a COVID-19 vaccine if they’re either:

at increased risk due to a health condition or because of a weakened immune system
living with someone who has a weakened immune system
If you have not had a 1st or 2nd dose yet, you're still eligible and should get them as soon as possible.

inanaco
29/4/2023
10:33
post 57101 -
What an embarrasing outburst of a post to make.

No doubt to be followed by more from the trHYPE gang attempting to detract from the REALITY of trHYPE ...FAILURES,

For more mentally balanced folks, it is quite amusing to watch.

the real lozan
29/4/2023
09:57
It's the weekend . . .

Andrew Bridgen MP was finally expelled from the Tory Party for claiming Covid vaccines were the “biggest crime against humanity since the Holocaust”. A simple dispassionate look at that statement tells ME that Bridgen is not in any way, diminishing the Holocaust itself - just perhaps exaggerating the ranking of covid vaccine damage against other World events, SINCE the Holocaust.

As Bridgen notes in the link below from Parliament TV, it seems the word 'SINCE' went over the heads of the readers.

Convenient - or part of a conspiracy of 'brush aside' . . . or were they hunting for him ?

It was a disgrace on the H o C that Bridgen made addresses about vaccine damage etc.to benches that were almost completely empty.

I am FOR good vaccines but as AB notes in passing, the AstraZeneca vaccine has quietly disappeared from the NHS and the current MRNA vaccines are no longer recommended for 6 month old babies - in fact, promoted now only for over 75's and those of extreme vulnerability.

Something is wrong - AB should IMO have been listened to, with minds more open.

In this link AB is (rightly IMO) bemoaning proposals from the WHO to give them far wider powers during the 'next' pandemic. I think that's an extremely bad idea.

At least this time, he has an audience

torquayfan
29/4/2023
06:46
P7 ... you have achieved nothing

Vaccines still got sold and orders for next season placed

Scancell is 100% functional ... and all those clever people have never heard of you

why waste your time "head banging" with lozan ? who has been at it far longer than you and achieved Diddly Squat and the only person to make money from Diddly Squat was Clarkson not loseran

however Gerald Cooper posting as Panama7 might explain a few things

inanaco
28/4/2023
21:41
Hoping for the next update soon.
marcusl2
28/4/2023
20:40
Marcus al the inventories and 15p is the bottom line.
golcheja
28/4/2023
20:36
All the product and still not one got commercialised. It’s a valid question why Scancell is not moving up. Not to say it’s not doing what it’s written on the tin but if one believe it does, then it’s based on speculation and hope. Simple to clarify the position and update…not much to ask after 19 years.
golcheja
28/4/2023
20:03
Did oh dear Inane, have I hit a nerve, is the share price weighing on you. I'm not surprised the pressure is getting to you, are things not turning out the way they were meant to. Isn't Lindy justifying your confidence in her.
panama7
28/4/2023
15:37
Dominic , so what exactly has Lindy achieved for investors in the last 10 years. Who has bought any of her products. Why did Goodfellow leave shortly after Moditope going into the clinic after waiting 10 years. Why did he immediately go and join another company if there is so much interest in Moditope. How many deals for preclinical medicines have been done in the last 10 years for multiples of scancell's market cap.
panama7
28/4/2023
12:46
Lozan
So you are much smarter than Lindy, two very large investment funds, Professor whatever that consults for Vulpes, every other investor.
Wow!

dominiccummings
28/4/2023
09:43
4m 20s Gilead paid $21 Billion for ADC

Our Glymabs have so much potential and ADCs/ Bi Specifics are hot. ADCs are going to replace Chemo in many settings as the antibody delivers Chemo only to the cancerous and not healthy cells.

marcusl2
27/4/2023
21:12
Modi-1

triple negative breast (TNBC),
ovarian,
renal,
head & neck cancer
Trinity estimate £3.5 billion peak sales 17.5% royalties
(seems too low imho if it works out)


Modi-2

breast,
colorectal,
non-small cell lung (NSCLC),
prostate cancer
(70% of animals treated with Modi-2 SNAPvax™ particles survived)

Immunobody DNA Platform
Melanoma
iSCIB1+ reduces tumour volume and increases survival
compared to SCIB1+ in preclinical model. 50% of iSCIB1+ animals treated survived

SC129
• Genmab licensed asset
• Pancreatic cancer

SC134
• TCB lead target
• Small cell lung cancer

SC2811
Any solid tumour Non-exclusive multiple licensing opportunity

SC88
• Colorectal cancer

SC27
• Ovarian cancer

Avidimab Non-exclusive multiple licensing opportunity
Trinity estimate £8.5 billion peak sales 8% royalty if it works out.

valuation £300.1m, equivalent to 36.7p ATM

marcusl2
27/4/2023
13:56
Keytruda: Q1 $5.8 billion, up 20%, ahead of estimates of $5.6 billion

Maybe $23 Billion for 2023

marcusl2
27/4/2023
11:34
Sitting duck here for a buyout

FT

Cancer drugs help AstraZeneca beat forecasts
Rise in sales of oncology treatments offset slide in revenues from Covid-19 medicines

j777j
Chat Pages: Latest  2436  2435  2434  2433  2432  2431  2430  2429  2428  2427  2426  2425  Older